Hyperactive ryanodine receptors in human heart failure and ischaemic cardiomyopathy reside outside of couplons by Dries, Eef et al.
Open Research Online
The Open University’s repository of research publications
and other research outputs
Hyperactive ryanodine receptors in human heart failure
and ischaemic cardiomyopathy reside outside of
couplons
Journal Item
How to cite:
Dries, Eef; Santiago, Demetrio J; Gilbert, Guillaume; Lenaerts, Ilse; Vandenberk, Bert; Nagaraju, Chandan K;
Johnson, Daniel M; Holemans, Patricia; Roderick, H Llewelyn; Macquaide, Niall; Claus, Piet and Sipido, Karin R
(2018). Hyperactive ryanodine receptors in human heart failure and ischaemic cardiomyopathy reside outside of
couplons. Cardiovascular Research, 114(11) pp. 1512–1524.
For guidance on citations see FAQs.
c© 2018 The Authors
Version: Version of Record
Link(s) to article on publisher’s website:
http://dx.doi.org/doi:10.1093/cvr/cvy088
Copyright and Moral Rights for the articles on this site are retained by the individual authors and/or other copyright
owners. For more information on Open Research Online’s data policy on reuse of materials please consult the policies
page.
oro.open.ac.uk
Hyperactive ryanodine receptors in human heart
failure and ischaemic cardiomyopathy reside
outside of couplons
Eef Dries, Demetrio J. Santiago†, Guillaume Gilbert, Ilse Lenaerts, Bert Vandenberk,
Chandan K. Nagaraju, Daniel M. Johnson, Patricia Holemans, H. Llewelyn Roderick,
Niall Macquaide‡, Piet Claus, and Karin R. Sipido*
Department of Cardiovascular Sciences, KU Leuven, Campus Gasthuisberg, Herestraat 49 Box 704, B-3000 Leuven, Belgium
Received 13 September 2017; revised 12 March 2018; editorial decision 27 March 2018; accepted 12 April 2018; online publish-ahead-of-print 31 May 2018
Time for primary review: 43 days
This article was handled by a consulting editor Ajay Shah.
Aims In ventricular myocytes from humans and large mammals, the transverse and axial tubular system (TATS) network
is less extensive than in rodents with consequently a greater proportion of ryanodine receptors (RyRs) not coupled
to this membrane system. TATS remodelling in heart failure (HF) and after myocardial infarction (MI) increases the
fraction of non-coupled RyRs. Here we investigate whether this remodelling alters the activity of coupled and non-
coupled RyR sub-populations through changes in local signalling. We study myocytes from patients with end-stage
HF, compared with non-failing (non-HF), and myocytes from pigs with MI and reduced left ventricular (LV) function,
compared with sham intervention (SHAM).
....................................................................................................................................................................................................
Methods
and results
Single LV myocytes for functional studies were isolated according to standard protocols. Immunofluorescent stain-
ing visualized organization of TATS and RyRs. Ca2þ was measured by confocal imaging (fluo-4 as indicator) and us-
ing whole-cell patch-clamp (37C). Spontaneous Ca2þ release events, Ca2þ sparks, as a readout for RyR activity
were recorded during a 15 s period following conditioning stimulation at 2 Hz. Sparks were assigned to cell regions
categorized as coupled or non-coupled sites according to a previously developed method. Human HF myocytes
had more non-coupled sites and these had more spontaneous activity than in non-HF. Hyperactivity of these non-
coupled RyRs was reduced by Ca2þ/calmodulin-dependent kinase II (CaMKII) inhibition. Myocytes from MI pigs had
similar changes compared with SHAM controls as seen in human HF myocytes. As well as by CaMKII inhibition, in
MI, the increased activity of non-coupled sites was inhibited by mitochondrial reactive oxygen species (mito-ROS)
scavenging. Under adrenergic stimulation, Ca2þ waves were more frequent and originated at non-coupled sites,
generating larger Naþ/Ca2þ exchange currents in MI than in SHAM. Inhibition of CaMKII or mito-ROS scavenging
reduced spontaneous Ca2þ waves, and improved excitation–contraction coupling.
....................................................................................................................................................................................................
Conclusions In HF and after MI, RyR microdomain re-organization enhances spontaneous Ca2þ release at non-coupled sites in a
manner dependent on CaMKII activation and mito-ROS production. This specific modulation generates a substrate
for arrhythmia that appears to be responsive to selective pharmacologic modulation.
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1. Introduction
Abnormal cellular Ca2þ handling and excitation-contraction coupling
contribute to reduced contractile function and arrhythmogenesis in
heart failure (HF).1 Ca2þ uptake into the sarcoplasmic reticulum (SR) by
SERCA, Ca2þ release through ryanodine receptors (RyRs), Ca2þ extru-
sion across the sarcolemma by the Naþ/Ca2þ exchanger (NCX), and
Ca2þ influx via L-type Ca2þ channels (LTCCs) all contribute to this pro-
cess. Novel Ca2þ pathways also emerge such as flux through TRP chan-
nels.2 Functional changes in Ca2þ handling occur through alteration in
protein expression or through post-translational modifications. Signalling
pathways involved in remodelling of Ca2þ handling include those medi-
ated by reactive oxygen species (ROS), Ca2þ/calmodulin-dependent ki-
nase II (CaMKII), and nitric oxide (NO). Loss of SR Ca2þ through ‘leaky’
RyRs is attributed to post-translational modifications of RyRs that lead to
alterations in RyR Ca2þ sensitivity and open probability (Po). In animal
models of disease, increased SR Ca2þ leak is observed after myocardial
infarction (MI) compared with control3 as well as in HF,4 diabetes,5 and
atrial fibrillation (AF).6 In human myocytes, greater Ca2þ leak was
reported in HF7 and AF8,9 although one study found that spontaneous
release events, Ca2þ sparks, were less frequent in HF.10 Ca2þ loss
through RyRs reduces contraction by decreasing the SR Ca2þ content,
and can be a trigger to induce arrhythmogenic Ca2þ waves through acti-
vation of NCX.
Changes in the subcellular architecture of cardiac myocytes with dis-
ease further modulate Ca2þ handling. Reduced density and disorganiza-
tion of the transverse and axial tubular system (TATS) is seen in post-MI
remodelling.11–13 These and other data suggest that TATS remodelling is
a general feature in the progression to HF.14 In contrast, RyR clusters ap-
pear to remain distributed at the Z lines throughout the cell, resulting in
a large fraction of RyRs that are no longer in close proximity to the sar-
colemmal (SL) membrane and TATS, i.e. outside couplons. Due to the
increased distance to LTCCs, these non-coupled RyRs cannot be acti-
vated directly by Ca2þ entry via LTCC but are activated with a delay
through Ca2þ-induced-Ca2þ-release propagating from coupled sites.
This dys-synchrony reduces the rise time and amplitude of the global
Ca2þ transient12,15–17 and contributes to impaired contractile function.
The architecture of TATS results in different signalling microdomains
around coupled and non-coupled RyRs. In healthy pig myocytes, coupled
RyRs have a unique NOX2- and CaMKII-dependent regulation during in-
creased heart rate and b-adrenergic stimulation.18,19 However, the link
between TATS remodelling in disease and the modulation of the larger
population of non-coupled RyRs is not well studied.
To date, changes in RyR function in human HF have been exclusively
studied at the myocyte level,7,20 without information on subpopulations
of RyRs, and mostly using HF myocytes only. Comparisons between
non-HF and HF are scarce.10 Recent work studied RyRs extracted from
left ventricular (LV) tissues samples from HF and non-HF and reconsti-
tuted in bilayers.21 In the pig with MI, we reported that TATS remodel-
ling affected properties of the RyR subpopulations but did not investigate
the signalling mechanisms involved.22 In a dog model of HF, Belevych
et al.23 found that RyR subpopulations had different characteristics.
However, little is known of the intrinsic properties, modulation, and
arrhythmogenic contributions of coupled vs. non-coupled RyRs in post-
MI remodelling or in human HF. Yet, selective targeting of modulators
controlling RyR Po has become of interest in the treatment of cardiac dis-
ease where impaired Ca2þ handling plays a role.24–26
Pilot data from our earlier work indicated that after MI, increased
spontaneous RyR activity was exclusively a feature of non-coupled sites.
However, no mechanistic explanation could be offered at the time.19
This study was designed: (i) to explore and validate the relevance
of differences in coupled and non-coupled RyR properties in human
HF; (ii) to study underlying mechanisms of the modulation of RyR
subpopulations and the arrhythmogenic consequences in post-MI
remodelling. Unlike in earlier work, here we induced MI in the
anterior wall,27 which has a larger impact on LV remodelling than MI
in the posterior wall.15,22
2. Methods
Permission for the use of tissue from human hearts in the heart
transplantation programme, explants, and non-used donor hearts, was
obtained from the Ethical Committee of the University Hospital (UZ
Leuven) with permit number S58824. The study conforms to the
Helsinki declaration. Patients received usual care HF medication and
data can be found in Supplementary material online, Tables S1 and S2.
Animals were housed and treated according to the Guide for the
Care and Use of Laboratory Animals (National Institute of Health, USA),
the European Directive 2010/63/EU and experimental protocols were
approved by the in-house ethical committee (Ethische Commissie
Dierproeven, KU Leuven), with permit numbers P10139, P14176, and
P16110.
Cell isolation, confocal microscopy, and electrophysiological record-
ings were performed as previously described.19 Single LV myocytes
were enzymatically isolated from explanted human hearts28 (failing, HF,
and non-failing, non-HF) and from pigs with MI in the anteroseptal re-
gion, with reduced LV function and cellular remodelling19,27 (see
Supplementary material online, Figures S1 and S2). In human hearts, myo-
cytes were obtained from the territory of the left anterior descendens
coronary artery (LAD), cannulating a diagonal side-branch. If the LAD
was not accessible, the left circumflex branch was used. In MI pigs,
myocytes from the peri-infarct regions were prepared by cannulating a
LAD side-branch and the same region was selected in SHAM animals.
We used low (0.5 Hz) and high (2 Hz) frequency stimulation in the
whole-cell voltage-clamp mode (-70 to þ10 mV); the Ca2þ indicator
fluo-4 was included in the pipette solution. Ca2þ sparks were recorded
for 15 s after stimulation during confocal line-scan imaging. Cells were
scanned along the longitudinal axis, orthogonal to the Z lines, avoiding
scanning through nuclei. All experiments were performed at 37C. Ca2þ
sparks were assigned to coupled/non-coupled release sites based on an
established algorithm.19 A per-pixel spark frequency was calculated and
normalized to give a measure in sparks/100 lm/s. Spark frequency was
normalized to the length of the line in coupled/non-coupled sites. Ca2þ
waves were induced at 2 Hz stimulation in the presence of isoproterenol
(ISO; 10 nM). Ca2þ wave incidence was normalized to number of waves/
100 mm/s and wave origins (pixel-based) were used to assign waves to
coupled/non-coupled sites.
Immunofluorescent imaging was performed in fixed isolated cells
or tissue sections. NCXwas used as a surrogate marker to report on TATS
membranes and distancemasks were constructed as previously described.19
From thesemasks, the fraction of coupled/non-coupled RyRs was calculated
and co-localization of coupled/non-coupled RyRs with CaMKII was quanti-
fied according to the Manders’ coefficient. To study TATS in relation to
subcellular Ca2þ release, non-fixed myocytes were stained with
wheat-germ-agglutinin-Alexa594 as described previously.19
Measurements of FAD/NAD(P)H for estimating redox potential were
performed at 37C under electrical field stimulation at various
RyR microdomains in post-MI remodelling and human HF 1513
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..frequencies by wide field fluorescence imaging using a Nikon TE2000
inverted microscope equipped with a 40 1.3 NA oil immersion objec-
tive and Hamamatsu Flash 4 CMOS camera. Endogenous fluorescent
FAD and NAD(P)H signals were measured: NAD(P)H was excited at
360/10 nm and emission was collected at 480/40 nm (500 ms), FAD was
excited at 485/20 nm and emission was collected at 535/30 nm (500 ms).
Excitation and emission filters were selected using filter wheels (Sutter)
and wavelengths discriminated using a triple band pass dichroic filter.
Images were collected at a frequency of a ratio pair every 20 s.
2.1 Statistics
All data are presented as means ± SEM. For statistical analysis, we used a
nested design taking into account n cells and N animals (freeware pro-
gramme R, R Core Team (2013). R: A language and environment for sta-
tistical computing.), and Student’s t-test or a two-way ANOVA with
Bonferroni post hoc testing as applicable. The Fisher’s exact test was used
to compare incidence of Ca2þwaves between different groups. Data were
considered significantly different when the probability value was < 0.05.
Detailed methods are provided in the Supplementary material online.
Figure 1 Myocyte hypertrophy and increased fraction of non-coupled release sites with an increased spark frequency in human HF. (A) Cell size and
TATS characteristics in non-HF (ncells = 27–31; Nhumans = 4) and HF (ncells = 83–91; nhumans = 5). Data are presented as mean value per subject. (B) Left:
Examples of confocal line-scan recording of Ca2þ transients in non-HF and HF. Middle and right: Distribution and quantification of TF50 of the Ca
2þ transient
in coupled (<14.5 ms) and non-coupled (>21.5 ms) sites in non-HF (ncells = 18; Nhumans = 4) and HF (ncells = 32; Nhumans = 5). (C) Left: Example of a confocal
line-scan recording using TF50 of the Ca
2þ transient to assign sparks to different release sites. Middle: Spark frequency in coupled and non-coupled sites in
non-HF (ncells = 22;Nhumans = 4) and Right: HF (ncells = 32;Nhumans = 6) (*P-value < 0.05; **P-value < 0.01; ***P-value < 0.001).
1514 E. Dries et al.
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3. Results
3.1 Myocyte hypertrophy and increased
fraction of non-coupled release sites in
human HF
HF myocytes were longer than non-HF, without difference in cell width
(Figure 1A). The density of TATS was significantly lower in HF myocytes
and axial tubules were more abundant (Figure 1A).
To identify RyR subpopulations in human myocytes, we used a previ-
ously described algorithm,19 establishing criteria as shown in the
Supplementary material online, Figure S3A. These pre-established criteria
allow studying of coupled and non-coupled release sites in a more rigor-
ous way than used previously,22,23 excluding intermediate release sites
(between > 0.5 and < 2 mm) (see Supplementary material online, Figure
S4). This approach still includes on average 80% of all release sites in all
groups. As shown by its rightward shift, the distribution of the time to
half-maximum of the Ca2þ transient (TF50) for all release sites was signifi-
cantly increased in HF myocytes (Figure 1B, middle). Quantification of
early (coupled) and late (non-coupled) sites confirmed the decrease in
the number of coupled sites and the increase of non-coupled sites in HF
(Figure 1B, right). These data indicate that in human HF, hypertrophy is
associated with an altered TAT network and an increased proportion of
non-coupled release sites.
3.2 Increased activity of non-coupled re-
lease sites in HF, dependent on CaMKII
In non-HFmyocytes, high-frequency stimulation caused a three-fold increase
in spark frequency in coupled sites compared with that observed under
low-frequency stimulation, whereas the spark frequency was only increased
by 1.5-fold in non-coupled release sites (Figure 1C, middle). In HF myocytes,
this frequency-dependent response was absent at coupled sites (Figure 1C,
right), despite a substantial increase in SR Ca2þ load at 2 Hz in both HF and
non-HF (Figure 2B); in HF SR Ca2þ content tended to be lower. In
contrast, frequency of sparks at non-coupled sites in HF myocytes was
significantly increased at 2 Hz (Figure 1C, right). The specific CaMKII inhibitor
autocamtide-2-related-inhibitory-peptide (AIP) significantly reduced this
hyperactivity in non-coupled regions without affecting spark frequency at
coupled sites (Figure 2A).
3.3 Slower and smaller global Ca2þ
transients in HF with beneficial effect of
CaMKII inhibition
A reduced synchrony of Ca2þ release has previously been shown to lead
to a slow rise of the Ca2þ transient in humanHFmyocytes.17 Herewe con-
firm that an increased fraction of non-coupled sites in HFmyocytes in com-
parison to non-HF leads to a slower upstroke and reduced amplitude of
the Ca2þ transient (Figure 2B). This dys-synchrony is further illustrated by
the delay in the fraction of the line-scan that reached half-maximal Ca2þ re-
lease in HF myocytes compared with non-HF. Interestingly, inhibition of
CaMKII that reduces diastolic release, removes the differences between HF
and non-HF for amplitude and rate of upstroke (Figure 2C).
3.4 Specific modulation of coupled sites is
lost after MI, whereas a de novo regulation
appears at non-coupled release sites
Having established remodelling of TATS and spark properties in human
HF, we used the post-MI pig model to gain further mechanistic
understanding. The pig shares many features of cardiac physiology with
humans, and ischaemic cardiomyopathy is the major cause of human HF.
The relevance of the pig MI model is further underscored by earlier pilot
data indicating that coupled and non-coupled release sites have proper-
ties similar to those seen here in human HF and CaMKII dependence
was similar to human HF.19
In MI myocytes in the present study, likewise the CaMKII inhibitor AIP
did not affect the spark frequency in coupled sites (Figure 3A), but
reduced the spark frequency in non-coupled release sites (Figure 3B, see
Supplementary material online, Figure S5A for baseline data). Global
Ca2þ transients in MI myocytes were smaller with reduced rate of up-
stroke, as in HF, and consistent with the loss of TATS and reduced syn-
chrony of Ca2þ release (see Supplementary material online, Figure S5B).
We further examined signalling and microdomains in the RyR subpo-
pulations focussing on ROS as a candidate for post-MI signalling. NOX2
signalling is known to change in cardiac disease29 and could be affected
because of the TATS remodelling, while changes in metabolism and mito-
chondrial function27 could affect mito-ROS production. In contrast to
SHAMmyocytes, inhibition of NOX2with gp91 ds-tat peptide, did not af-
fect the spark frequency in coupled sites after MI (Figure 3A). Since non-
coupled sites lack TATS, NOX2-generated ROS at the TAT membrane
is unlikely to affect non-coupled RyRs as confirmed by the lack of an effect
of gp91 application (see Supplementary material online, Figure S6). Using
the global ROS scavenger, NAC, we probed for ROS-mediated modula-
tion from other sources. NAC significantly reduced the spark frequency
in non-coupled sites (Figure 3B). None of these interventions affected the
SR Ca2þ load (see Supplementary material online, Figure S7B and C).
3.5 CaMKII and NOX2 localization is intact
after MI
The lack of frequency-response in coupled release sites after MI could
be attributed to the specific loss of CaMKII and/or NOX2 in coupled
regions. In both SHAM and MI myocytes, there was however a similar
degree of co-localization between CaMKII and coupled or non-coupled
RyRs (Figure 4Aa). No change in CaMKII expression in SHAM and MI tis-
sue was detected (see Supplementary material online, Figure S8). The lo-
calization of NOX2 at the TATS was intact after MI (Figure 4Ab, see
Supplementary material online, Figure S9A and B).
3.6 Reduced [Ca2þ] and ROS scavenging in
the dyadic cleft after MI
A potential mechanism for the lack of CaMKII activation in coupled regions
after MI remodelling is the loss of high Ca2þ microdomains in the dyadic
cleft. We analysed local [Ca2þ] by measuring ICaL inactivation and local
Ca2þ transient kinetics. The early inactivation of ICaL was decreased (larger
Taufast), indicating reduced [Ca
2þ] near LTCC (Figure 4B). In addition, the
amplitude and rate of upstroke of Ca2þ transients in regions of coupled
sites were reduced (see Supplementary material online, Figure S5C).
We tested the hypothesis that changes in NOS1 could reduce ROS in
the dyadic cleft, as e.g. produced by local NOX2 (Figure 4C). Recently, lo-
cal ROS scavenging mechanism at the SR have been described, whereby
NOS1-derived NO can scavenge xanthine oxidase (XO)-produced
ROS.30 During disease, NOS1 has been shown to translocate from the
SR to the TATS.31 Translocated NOS1-derived NO at the TATS could
thus mask a local ROS microdomain by scavenging ROS produced by
NOX2 in MI myocytes. Inhibition of NOS1 with L-NAME, and with the
more specific L-VNIO produced a significant increase in the spark fre-
quency in coupled sites in MI myocytes to a similar level as in control.
RyR microdomains in post-MI remodelling and human HF 1515
Figure 2 CaMKII inhibition normalized both RyR activity and Ca2þ transients in human HF myocytes. (A) The effect of AIP in coupled and non-coupled
sites in non-HF (ncells = 19; Nhumans = 4) and HF (ncells = 23; Nhumans = 6). (B) Ca
2þ transient amplitude in non-HF (ncells = 19; Nhuman = 4) and HF (ncells = 25;
Nhuman = 6) at 2 Hz stimulation with examples of line-scan and reduced synchrony. The fraction of the line-scan with at least half-maximal Ca
2þ release as a
function of time. SR Ca2þ content in non-HF and HF at 0.5 Hz (ncells = 8;Nhumans = 4 in non-HF; ncells = 16;Nhumans = 6 in HF) and 2 Hz (ncells = 11;Nhumans =
4 in non-HF; ncells = 20;Nhumans = 6 in HF). (C) Ca
2þ transient amplitude in non-HF (ncells = 19;Nhuman = 4) and HF (ncells = 25;Nhuman = 6) at 2 Hz and the ef-
fect with AIP (non-HF: ncells = 19;Nhuman = 4 and HF: ncells = 23;Nhuman = 6) (*P-value < 0.05; **P-value < 0.01; ***P-value < 0.001).
1516 E. Dries et al.
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..NOS inhibition did not affect the frequency-response in coupled sites in
SHAMmyocytes (Figure 4C).
3.7 ROS frommitochondria modulate non-
coupled RyRs after MI
The data in Figure 3B imply that there must be an alternative ROS source
to NOX2 affecting the non-coupled sites in MI. We hypothesised that
the mitochondria were responsible. Scavenging mitochondrial ROS
(mito-ROS) using mitoTEMPO significantly reduced spark frequency at
non-coupled regions in MI, without affecting coupled sites (Figure 5A);
there was no effect in SHAM. SR Ca2þ content was unchanged by
this manoeuver in SHAM or MI (see Supplementary material online,
Figure S7B and C). Inhibition of XO with oxypurinol had no effect on
sparks in either SHAM or MI myocytes (see Supplementary material
online, Figure S10) indicating that this enzyme did not contribute to ROS
generation. These observations raised the question whether pacing at
2 Hz selectively induced mito-ROS in MI but not in SHAM. To test this
possibility, we studied cellular redox potential through measuring the
FAD/NAD(P)H ratio. During stimulation at 2 Hz, the NAD(P)H signal
Figure 3 CaMKII-dependent and ROS-dependent signalling examined at coupled vs. non-coupled sites after MI in pig ventricular myocytes. (A) Left: The
effect of AIP in coupled sites in MI (ncells = 16; Npigs = 7) and SHAM (ncells = 15; Npigs = 4). Right: The effect of gp91 ds-tat peptide in coupled sites in MI (ncells
= 14;Npigs = 4) and SHAM (ncells = 13; Npigs = 4). (B) Left: The effect of AIP in non-coupled sites in MI (ncells = 16; Npigs = 7) and SHAM (ncells = 15; Npigs = 4).
Right: The effect of NAC in non-coupled sites in MI (ncells = 10;Npigs = 5) and SHAM (ncells = 10;Npigs = 3) (*P-value < 0.05; **P-value < 0.01).
RyR microdomains in post-MI remodelling and human HF 1517
Figure 4 Ca2þ and ROS in the dyadic cleft after MI in pig myocytes. (A) a. Example of a confocal image of a pig ventricular myocyte stained for RyR (blue),
CaMKII (green), and NCX (red). The co-localization of CaMKII in coupled and non-coupled RyRs is shown using the Manders’ coefficient in SHAM (ncells =
26; Npigs = 6) and MI (ncells = 32; Npigs = 7). b. Example of tissue samples in SHAM and MI stained for gp91 (red), NCX (green) and overlay (yellow). Scale
bar equals 5 mm. (B) Example and mean values of ICaL inactivation in SHAM (ncells = 19; Npigs = 3) and MI (ncells = 24; Npigs = 5). (C) The effect of L-NAME
(ncells = 14; Npigs = 4) and L-VNIO (MI: ncells = 15; Npigs = 4; SHAM: ncells = 12; Npigs = 3) in coupled sites in MI and SHAM (*P-value < 0.05; **P-value < 0.01;
***P-value < 0.001).
1518 E. Dries et al.
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decreased while the FAD signal increased. Comparison of the ratio of
these changes between SHAM and MI revealed a greater increase in
FAD/NAD(P)H in MI myocytes (Figure 5Bb).
3.8 After MI, Ca2þ waves are more frequent
and originate in non-coupled release sites
Increased RyR activity/sensitivity may result in spontaneous Ca2þ waves
that promote arrhythmias. We investigated the susceptibility for Ca2þ
waves in MI during b-adrenergic stimulation at 2 Hz, mimicking the in vivo
adrenergic effects.
MI myocytes exhibited more Ca2þ waves than SHAM, and these
Ca2þ waves generated significantly larger NCX currents (INCX) (Figure
6B). This was reflected by an increased number and amplitude of
delayed-afterdepolarizations (DADs) as well as an increase in number of
spontaneous action potentials (APs) (Figure 6C). We related the source
of Ca2þ waves to either coupled and non-coupled sites based on the
TF50 of the Ca
2þ transient. A distribution plot shows that after MI, Ca2þ
waves originated more frequently from non-coupled sites (Figure 6D).
To induce triggered activity, and ultimately arrhythmias, membrane de-
polarization by the inward INCX generated by the Ca
2þ waves must reach
the threshold for AP generation. Larger INCX is generated when multiple
Ca2þ waves collide. In MI, more cells exhibited colliding Ca2þ waves com-
paredwith SHAM (Figure 6Ea). These colliding waves had a larger amplitude
and INCX compared with single Ca
2þ waves in MI myocytes (see
Supplementary material online, Figure S11). Colliding waves originating from
non-coupled sites had the highest peak and integrated INCX (Figure 6Eb).
3.9 Inhibition of CaMKII and mito-ROS
reduces Ca2þ waves from non-coupled sites
in MI
In MI myocytes, mitoTEMPO and AIP reduced the increased wave
frequency originating from non-coupled sites without significantly
affecting those arising from coupled regions (Figure 7A). Direct inhibition
of RyR opening with flecainide or S107 reduced Ca2þ waves in both MI
and SHAM.
We assessed the impact of these interventions on excitation-
contraction coupling and the Ca2þ transient. Flecainide, CaMKII and
mitoTEMPO did not affect the Ca2þ transient amplitude, whereas S107
significantly reduced the amplitude in both SHAM and MI myocytes
(Figure 7B).
4. Discussion
TATS remodelling in ventricular myocytes after MI and in HF, leads to an
increase in non-coupled release sites. Unlike in the healthy heart, these
Figure 5 Mito-ROS microdomain affects non-coupled sites after MI in pig myocytes. (A) The effect of mitoTEMPO on spark frequency in coupled and
non-coupled sites in MI (ncells = 14; Npigs = 4) and SHAM (ncells = 13; Npigs = 5). (B) a. Example traces of NAD(P)H and FAD signals, measured over time as
the mean fluorescence intensity, in SHAM and MI at 2 Hz. b. For each cell, the FAD/NAD(P)H ratio measured after pacing at 2 Hz was normalized to the
rest value. The graph represents the frequency distribution with the fitted Gaussian curves in SHAM andMI (*P-value < 0.05; ***P-value < 0.001).
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Figure 6 Ca2þ wave frequency increases and Ca2þ wave origin shifts towards non-coupled release sites after MI in pig myocytes. (A). Examples of Ca2þ
waves in SHAM and MI are shown. (B) Wave frequency (SHAM: ncells = 59; Npigs = 13, MI: ncells = 62; Npigs = 16), wave-induced Ca
2þ transient amplitude
(SHAM: nwaves = 30 in ncells = 25 inNpigs = 9; MI: nwaves = 49 in ncells = 38 in Npigs = 11) and wave-induced INCX (SHAM: nwaves = 59 in ncells = 32 in Npigs = 9;
MI: nwaves = 91 in ncells = 38 in Npigs = 11) for SHAM and MI. (C) DAD incidence, DAD amplitude and spontaneous APs in SHAM (ncells = 28; Npigs = 6) and
MI (ncells = 34; Npigs = 7). (D) Left: Waves are assigned to coupled or non-coupled release sites by using the wave origin (pixel-based) and TF50 of the Ca
2þ
transient. Middle: The distribution of wave origins and Right: wave frequency in SHAM (ncells = 39; Npigs = 9) and MI (ncells = 62; Npigs = 16). (E) a. Example
and quantification of colliding and single waves in SHAM andMI. b. Ca2þ wave peak INCX and integrated INCX in coupled and non-coupled sites in SHAM and
MI. Colliding waves are indicated in green. Only colliding waves are included when originating from only coupled or non-coupled sites. (nwaves = 11–28, ncells
= 32–38,Npigs = 9–11) (*P-value < 0.05; **P-value < 0.01; ***P-value < 0.001).
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..sites, outside of couplons, exhibit increased spontaneous activity during
diastole at higher heart rates. This arises through distinct alterations in
Ca2þ and ROS microdomains around the different RyR populations.
After MI, non-coupled release sites are at the origin of Ca2þ waves.
These Ca2þ waves generate larger depolarizing currents by simulta-
neously activating multiple Ca2þ release sites, thereby highlighting the
arrhythmogenic potential of these sites.
4.1 TATS remodelling in human HF
impacts on RyR activity and global Ca2þ
transient properties
We observed a significant reduction in TATS density, predominantly of
the T-tubules (TTs) in HF, extending earlier studies in human tissue.
Early electron microscopy studies described dilated TTs.32 Other fea-
tures previously described include an irregular distribution,11,17 an in-
crease in TT diameter11 and a reduction in TT density.33–35
TATS remodelling results in an increased fraction of non-coupled RyR
cluster sites, in line with data from a canine model of HF36 and human
HF myocytes.35 This remodelling is associated with loss of synchrony
and reduced amplitude of the Ca2þ transient through delayed opening
of the non-coupled RyRs. Similar findings were reported in animal mod-
els12,13,15 but data from human HF are scarce or did not include informa-
tion from non-HFmyocytes.17,35
This study also adds new information regarding the intrinsic proper-
ties of RyRs clusters at coupled and non-coupled sites. Indeed, previous
studies have only reported on overall RyR activity recorded as sparks in
diastole and in lipid bilayer experiments, without distinguishing subpopu-
lations.7,21,37 They mostly report an increase in total spark frequency, al-
though Lindner et al.10 reported a decrease in HF. An important
difference between the aforementioned study and ours is that we stud-
ied cells under voltage-clamp. The voltage-clamp mode with controlled
membrane potential and equal duration of membrane depolarization
achieves a more equal SR load and Ca2þ fluxes allowing better dissection
of RyR properties with less influence of confounding factors (including
disease associated remodelling of the AP and resting membrane poten-
tial). Our finding that the spark activity in non-coupled sites is sensitive to
CaMKII inhibition is in line with previous reports on RyR properties
in HF, although a comparison to non-HF was not included in those stud-
ies.7,37 Recently, lipid bilayer experiments on RyR activity support these
findings, with a major role for RyR phosphorylation and thiol oxidation in
HF conditions.21 In line with the study from Fischer et al.,7 no differences
in response to CaMKII inhibition were found between myocytes from
ischaemic and dilated cardiomyopathy (see Supplementary material on-
line, Figure S12). The data complement earlier work on the global assess-
ment of Ca2þ transients in HF vs. non-HF human myocytes.38 Our data
further show that in HF, CaMKII inhibition can reduce diastolic events
with favourable effects on the global Ca2þ transient.
Figure 7 Non-coupled release sites are more sensitive to RyR blockers and inhibition of RyR modulators after MI in pig myocytes. (A) Effects of
flecainide (SHAM: ncells = 27;Npigs = 5; MI: ncells = 26;Npigs = 6), S107 (SHAM: ncells = 19; Npigs = 3; MI: ncells = 27; Npigs = 4), AIP (SHAM: ncells = 22; Npigs = 3;
MI: ncells = 25; Npigs = 9) and mitoTEMPO (MI: ncells = 23; Npigs = 5) on (A) wave frequency and (B) global Ca
2þ transient in SHAM and MI (*P-value < 0.05;
**P-value < 0.01).
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4.2 Loss of dyadic cleft CaMKII signalling
after MI
Despite its presence at both coupled and non-coupled RyR clusters, we
did not detect CaMKII activation in the dyadic cleft near coupled sites in
MI, an effect possibly due to reduced [Ca2þ] in this microdomain.39 This
could be a primary event after MI with several potential causes. The SR
Ca2þ content is not reduced, excluding this possibility. Reduced coupling
gain between LTCC and RyR is another possibility, as in the rabbit with
HF.16,40 Litwin et al.16 proposed a different molecular configuration of
LTCC as the underlying mechanism whereas Bryant et al. reported a re-
distribution of ICaL away from the TT.
40,41 Another possibility is the
structure of the RyR cluster. Cluster size and organization affect Po
42,43
and may change in disease as recently reported for AF.44
Furthermore, Erickson et al.45 recently reported that exposure to
NO prior to Ca2þ/CaM binding to CaMKII strongly suppresses CaMKII
activity. This could explain the loss of CaMKII activation in coupled
regions after MI, in line with the increased spark frequency with NOS in-
hibition. NO production may mask the ROS microdomain through
translocation of NOS1 from the SR to the TATS. This may be through
ROS in the dyadic cleft or ROS frommitochondrial sources.
Another possible mechanism may be through dysregulation of local-
ized antioxidant mechanisms. Glyceraldehyde 3-phosphate dehydroge-
nase, located at the TATS,46 potentially regulates the redox state at
SR–SL junctions by the production of NADH. In support of this notion,
ischaemic and dilated cardiomyopathies are known to cause a shift in
metabolic substrate utilization from free fatty acids to glucose,27,47
thereby increasing the rate of glycolysis and associated NADH produc-
tion, resulting in ROS scavenging at the dyadic cleft.
4.3 Non-coupled release sites have
increased spontaneous activity
Our data show a de novo form of modulation of non-coupled sites, de-
pendent on CaMKII activation and mito-ROS. Increased CaMKII activity
in the regulation of RyRs has been associated with several cardiac dis-
eases7,37,48,49 but its selective activation at non-coupled regions was so
far not reported. The low rate of upstroke of triggered Ca2þ release in
non-coupled regions makes it unlikely that CaMKII is activated by Ca2þ
in non-coupled regions. Instead, our data suggest a more prominent role
for mito-ROS, rather than Ca2þ, in the activation of CaMKII, as recently
shown in diabetic mouse heart.50 Moreover, increased levels of mito-
ROSmanifest in patients51 and animals with advanced HF.52–54
The increased activity of RyRs at non-coupled sites in MI occurs without
apparent change in SR Ca2þ content. We could not yet study the full rela-
tionship between SR leak and content.55 It is conceivable that our experi-
ments occur at the exponential part of this relationship together with a shift
in the curve due to RyR post-translational modifications. Therefore, one
can have increased leak with small or no changes in SRCa2þ content.
4.4 Non-coupled sites are hotspots for
arrhythmogenic Ca2þ waves
The increased wave frequency that we observe make non-coupled
RyR clusters a potential source of deleterious Ca2þ handling in MI. In
contrast, Belevych et al.23 recently proposed that potential arrhythmo-
genic Ca2þ waves arise from coupled sites in myocytes from the dog
with pacing-induced HF. This opposing finding may reflect species
differences and different types of remodelling, as there was no loss of TT
in this HF model. Also, differences in experimental conditions may help
to explain the different findings between the two studies. Belevych
et al.23 recorded at room temperature and 0.5 Hz pacing, in contrast to
37C and 2 Hz pacing frequency in this study. Of note, at 0.5 Hz condi-
tioning, we did not see the distinguishing activity between coupled and
non-coupled RyRs.
Inhibition of diastolic RyR Ca2þ leak could be a therapeutic strategy
with direct RyR block or modulation.24–26 In this study, Ca2þ waves were
reduced by both RyR blockade and inhibition of RyR modulation. The
S107 and flecainide-dependent reduction in Ca2þ wave frequency is in
line with data previously reported under various conditions,24,26 although
how flecainide reduces Ca-wave dependent arrhythmias is debated.56
The role of CaMKII in arrhythmias has been previously investigated,57
including ROS-induced CaMKII activation.58,59 Here we show that CaMKII
inhibition in MI selectively reduced waves originating from non-coupled
RyRs without adverse effects on coupled RyRs and excitation-contraction
coupling. CaMKII inhibition or mito-ROS scavenging would thus be better
strategies than direct RyR inhibition, which is less discriminating.
Last, the impact of waves on depolarizing currents was larger in MI. This
may at first glance be counterintuitive as non-coupled sites are more dis-
tant from the membrane. However, this distance may also cause a tempo-
rary increased re-circulation of Ca2þ in the stores with eventually larger
cell-wide Ca2þ release, colliding waves, larger INCX, and ultimately, trig-
gered activity. In a pilot study, in vivo monophasic AP from the peri-infarct
region during 2 Hz pacing and isoproterenol support the occurrence of
high amplitude DADs (see Supplementary material online, Figure S13),
whereas only low amplitude DADs were observed in SHAM animals. In
three out of five MI pigs, this pro-arrhythmic pacing protocol triggered
premature ventricular complexes in vivo. This was rarely observed in
SHAM animals.
4.5 Limitations and future directions
Human samples are limited in nature and quantity and not available for
all experiments. Nevertheless, our key observations in pig suggest com-
parable mechanisms after disease remodelling in human HFmyocytes.
In this study, only indirect and global ROS measurements were used
although development of local ROS measurements could provide
further insights. For local [Ca2þ], targeted probes are available but cell
culture60–62 complicates the application as culture affects TT ultrastructure.
Our biochemical characterization of RyR and CaMKII modifications
remains limited. No differences were found for the direct oxidation of
RyR between SHAM and MI tissues (see Supplementary material online,
Figure S14A). Immunostainings for both phosphorylation and oxidation
of CaMKII showed a significant increase in MI myocytes (see
Supplementary material online, Figure S14B and C). These approaches
are however not sufficient to detect dynamic changes during live cell
experiments at the subcellular level. In the current experiments, we have
relied on pharmacological tools and despite the use of different agents
and controls, there is always the potential for non-selective or indirect
effects. This limitation was preferred over gene manipulation that
requires cell culture, introducing other potential confounders.
In this work, a fraction of nearly 20% of non-coupled RyRs was ob-
served in SHAM pig myocytes using functional and immunostaining
methods (see Supplementary material online, Figure S1). This is high
compared with studies in human tissues, including present data, and dog
myocytes.35,63 Species-specific and methodological differences might ac-
count for some of this apparent disparity. Here and in our previous
work,19 we predominantly rely on the relationship between SR Ca2þ re-
lease and TATS distance to identify RyR subgroups. If not all RyRs are ac-
tive this may introduce discrepancies.
1522 E. Dries et al.
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5. Conclusion
In HF and after MI, RyR microdomain organization enhances spontane-
ous Ca2þ release and sparks from non-coupled sites, in a manner that is
dependent on CaMKII activation and mito-ROS production. This specific
modulation may generate a substrate for arrhythmia that appears to be
responsive to selective pharmacologic modulation.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
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